본문 바로가기

StemRegenin-1 Attenuates Endothelial Progenitor Cell Senescence by Regulating the AhR Pathway-Mediated CYP1A1 and ROS Generation

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
CELLS12(15) · #2005 · 2023
피인용
Web of Science 20Scopus 19
FWCI (Scopus)
1.03
JCR IF
JCR 2022 6
ISSN
2073-4409

저자

  1. 임혜지제1저자Pusan Natl Univ, Med Res Inst, Sch Med, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan 50612, South Korea
  2. 장웅비Pusan Natl Univ, Med Res Inst, Sch Med, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan 50612, South Korea
  3. 비노스 쿠마르 레티네스와란Pusan Natl Univ, Med Res Inst, Sch Med, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan 50612, South Korea
  4. 최재우Pusan Natl Univ, Med Res Inst, Sch Med, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan 50612, South Korea
  5. 이은지Pusan Natl Univ, Med Res Inst, Sch Med, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan 50612, South Korea
  6. 박상미Pusan Natl Univ, Med Res Inst, Sch Med, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan 50612, South Korea
  7. 정여름Pusan Natl Univ, Med Res Inst, Sch Med, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan 50612, South Korea
  8. 하종성Pusan Natl Univ, Med Res Inst, Sch Med, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan 50612, South Korea
  9. 윤지수Pusan Natl Univ, Med Res Inst, Sch Med, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan 50612, South Korea
  10. 최영진Pusan Natl Univ, Sch Med, Dept Hematooncol, Yangsan 50612, South Korea
  11. Hong, Young Joon교신저자Chonnam Natl Univ, Chonnam Natl Univ Hosp, Sch Med, Dept Cardiol, Gwangju 61469, South Korea
  12. 권상모교신저자Pusan Natl Univ, Med Res Inst, Sch Med, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan 50612, South Korea

초록

Endothelial progenitor cell (EPC)-based stem cell therapy is a promising therapeutic strategy for vascular diseases. However, continuous in vitro expansion for clinical studies induces the loss of EPC functionality due to aging. In this study, we investigated the effects of StemRegenin-1 (SR-1), an antagonist of aryl hydrocarbon receptor (AhR), on replicative senescence in EPCs. We found that SR-1 maintained the expression of EPC surface markers, including stem cell markers, such as CD34, c-Kit, and CXCR4. Moreover, SR-1 long-term-treated EPCs preserved their characteristics. Subsequently, we demonstrated that SR-1 showed that aging phenotypes were reduced through senescence-associated phenotypes, such as & beta;-galactosidase activity, SMP30, p21, p53, and senescence-associated secretory phenotype (SASP). SR-1 treatment also increased the proliferation, migration, and tube-forming capacity of senescent EPCs. SR-1 inhibited the AhR-mediated cytochrome P450 (CYP)1A1 expression, reactive-oxygen species (ROS) production, and DNA damage under oxidative stress conditions in EPCs. Furthermore, as a result of CYP1A1-induced ROS inhibition, it was found that accumulated intracellular ROS were decreased in senescent EPCs. Finally, an in vivo Matrigel plug assay demonstrated drastically enhanced blood vessel formation via SR-1-treated EPCs. In summary, our results suggest that SR-1 contributes to the protection of EPCs against cellular senescence.

키워드

StemRegenin-1human endothelial progenitor cellsAhR pathwayreactive oxygen speciesreplicative senescenceARYL-HYDROCARBON RECEPTORSTEM-CELLSMECHANISMSDISEASECD34ACTIVATIONEXPRESSIONEXPANSIONPROMOTEGENE

식별자

Scopus EID
2-s2.0-85167595120
WoS UID
001046163800001